trans-ISA247 autoimmune data

Interim results from a double-blind, placebo- and moxifloxacin-controlled, U.S. QTc trial in 160 healthy volunteers showed that at therapeutic doses (0.5 mg/kg) no ECG changes or QTc signals were seen...